Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center and Oregon Health & Science University.

LEARN MORE

SEE ALL NEWS

Recent Posts

Lymph Node-Like Structures May Trigger the Demise of Cancer Tumors How Hypoxia Helps Cancer Spread Computational Tool Developed to Predict Immunotherapy Outcomes for Patients with Metastatic Breast Cancer Study Suggests a Healthy Diet May Help Keep Low Grade Prostate Cancer From Progressing to More Dangerous States During Active Surveillance Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models Johns Hopkins Joins Cancer AI Alliance AI ‘Liquid Biopsies’ Using Cell-Free DNA, Protein Biomarkers, Could Aid Early Detection of Ovarian Cancer A Common Culprit Drives Prostate Cancer Progression Immunotherapy Before and After Lung Cancer Surgery Reduces Death Risk, Disease Recurrence